CTRI/2018/10/016050尚未招募4 期
A randomized, controlled, comparative study to assess the efficacy and safety of Acne-Pro Gel in treatment of acne
Gods Own Store LLP A Amritpuri opp Iskcon Temple East of Kailash New Delhi India0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Participants must be adults, aged 18-45 years old with mild to moderate facial acne with 10-100 lesions.
- •2.Should have an acne grade of at least 2.
- •3.Females Subjects must have a negative pregnancy test. Pregnant patients or individual with history of pregnancy will be excluded from the study.
- •4.Participants should be willing to sign a written consent for participation in the study and undergo a baseline interview.
- •5.Participants must be willing to apply the test product and return for assessment visits for evaluation.
- •6.Participants must agree that during the study they will refrain from taking any new herbal supplement and prescription or nonprescription medications treatment that has not been recommended by the study physician.
- •7. Participants must agree to take healthy diet and life style.
排除标准
- •1.Participants with more than 2 acne nodules.
- •2.Single or married subjects who are pregnant or have borne children in past one year.
- •3.Participants with a current skin disease other than acne.
- •4.Participants with facial hair that may obscure acne lesions.
- •5.Participant with a history of Use of topical or systemic steroids OR topical or systemic antibiotics within the last 2 or 4 weeks, respectively; Use of topical acne treatments (eg. benzoyl peroxide, salicylates, retinoids) within the last 2 weeks OR Use of systemic retinoids within the past 6 months
- •6.Participant undergone procedures on the face such as peels, laser therapy or microdermabrasion within the past 4 weeks
- •7.Women of childbearing potential not using a reliable contraceptive method. Participants taking oral contraceptives must have been taking their current contraceptive for the previous 3 months and must agree to continue with it until study completion. Concurrent diseases which exclude the administration of therapy as outlined by the study protocol
- •8.Participant with a evidence of concurrent disease that exclude administration of therapy as outlined by the study protocol.
- •9.Participant with history or presence of Serious, uncontrolled disease (including serious psychological disorders) likely to interfere with the study and/or likely to cause death within the study duration.
- •10.Subjects who, in the opinion of the investigator, abuse alcohol or drugs
- •4.Patients reporting use of prescription or non-prescription drugs that has not been pre-approved by the study physician.
- •5.Participant with known allergies to the main components of the test or comparator product.
- •6.Participation in another clinical trial or taking an investigational product in the past three months
- •7.Any participant who is not able to give informed consent.
研究者
相似试验
已完成
不适用
A randomized, controlled study comparing the efficacy of peginterferon alfa-2b plus standard or reduced dose ribavirin in serotype 2 chronic hepatitis CJPRN-C000000402Tokai University School of Medicine120
招募中
4 期
controlled study between erector spinea plane block versus paravertebral nerve block in neonates undergoing tracheo-esophageal fistula repairNeonatal DiseasesAnaesthesiaPACTR201908568919626Faculty of Medicine40
尚未招募
Unknown
A study to compare the accuracy of using ultrasound versus landmark guided method for locating subarachnoid space in patients having cesarean delivery under spinal anaesthesiaCTRI/2024/08/071890lady hardinge medical college
已完成
2 期
Clinical Trial of herbal formulation (GP/PROD/2021/004) in acute cough and throat irritatioCTRI/2022/01/039180Mr Kamlesh Thummar66
尚未招募
不适用
A randomized, evaluator-blind comparative study with a long-term extension to evaluate performance and safety of Belotero® Balance and no-treatment control for the treatment of facial acne scarsfacial acne scarsL90.5Scar conditions and fibrosis of skinDRKS00021121Rosenpark Research GmbH40